Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1996
03/12/1996US5498618 4-amino-N-(4-methyl-4-piperidinyl)-2-methoxybenzamides for treating smooth muscle contraction disorders
03/12/1996US5498617 Bone disorders
03/12/1996US5498616 Cysteine protease and serine protease inhibitors
03/12/1996US5498614 Bridged aza-bicyclic derivatives as substance P antagonist
03/12/1996US5498613 Dipyridamole and analogs thereof in preventing adhesion formation
03/12/1996US5498611 Ellipticine compounds
03/12/1996US5498608 Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
03/12/1996US5498607 Anticholesterol agents
03/12/1996US5498606 Protection of human and animal cells
03/12/1996US5498603 Tannic acid, debriding agent
03/12/1996US5498602 Viricide active against hiv
03/12/1996US5498522 Methods for the use of spermidine/spermine N1 -acetyltransferase as a prognostic indicator and/or a tumor response marker
03/12/1996US5498428 Treatment of hypertension by oral administration of potassium bicarbonate
03/12/1996US5498427 Solutions for the perfusion, preservation and reperfusion of organs
03/12/1996US5498423 Method for correcting plasma melatonin levels and pharmaceutical formulation comprising melatonin
03/12/1996US5498418 Nitroglycerine plaster and process for its production
03/12/1996US5498410 Method for the treatment of eosinophil-associated conditions with anionic polymers
03/12/1996US5498405 Indole alkaloids useful as UV protective and anti-inflammatory agents
03/12/1996CA2092402C Anticoccidial and growth promoting polycyclic ether antibiotic
03/12/1996CA2077996C Roquinimex for supportive use
03/12/1996CA2046943C Process for producing an agent with the active substance flupirtine to combat muscular tension
03/12/1996CA2016182C Heterocyclicguanidines as 5ht- antagonists
03/12/1996CA1338143C Enzymatic preparation of clavulanic acid and its precursor
03/12/1996CA1338141C Process for production of avermectins and cultures therefor
03/10/1996CA2157835A1 Hemopoietic function-stimulating agent
03/10/1996CA2131782A1 Methods
03/10/1996CA2131754A1 Prostaglandin e derivatives in the treatment of dementia
03/09/1996CA2157837A1 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
03/07/1996WO1996007096A1 AN IN VITRO SYSTEM FOR DETERMINING FORMATION OF Aβ AMYLOID
03/07/1996WO1996006941A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
03/07/1996WO1996006867A1 Method for controlling o-desulfation of heparin and compositions produced thereby
03/07/1996WO1996006855A1 NEW PEPTIDE DERIVATIVES WITH δ OPIOID RECEPTOR ANTAGONIST OR MIXED ν AGONIST/δ ANTAGONIST EFFECTS
03/07/1996WO1996006854A1 Spirostanyl glycosidal crystals
03/07/1996WO1996006849A1 Novel phosphane oxides, method of preparing them and drugs containing these compounds
03/07/1996WO1996006848A1 NEW THIAZOLO[3,2-a]QUINOLINE AND THIAZOLO[3,2-a]NAPHTHYRIDINE DERIVATIVES
03/07/1996WO1996006845A1 Substituted 9-alkyladenines
03/07/1996WO1996006844A1 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol succinate as antiviral agent
03/07/1996WO1996006842A1 Salts of an anti-migraine indole derivative
03/07/1996WO1996006841A1 Quinazoline derivative
03/07/1996WO1996006840A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
03/07/1996WO1996006837A1 Isoxazoles
03/07/1996WO1996006832A1 Novel 4-aminopyridazines, method of preparing them and drugs containing these compounds
03/07/1996WO1996006825A1 Guanidinomethyl cyclohexane carboxylic ester derivative
03/07/1996WO1996006821A1 Neurotrophic and antiproliferative compounds
03/07/1996WO1996006640A1 Bioadhesive-wound healing composition
03/07/1996WO1996006639A2 Novel drugs containing chelate-forming agents
03/07/1996WO1996006635A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound
03/07/1996WO1996006623A1 Antithrombotic and non-hemorrhagic heparin-based compositions, method for their preparation and therapeutic applications
03/07/1996WO1996006622A1 Hyaluronic acid and derivatives for modulation of cellular activity
03/07/1996WO1996006620A2 Lipid analogs for treating viral infections
03/07/1996WO1996006618A1 Cosolvent parenteral formulation of tirilazad
03/07/1996WO1996006617A1 Liposome preparation
03/07/1996WO1996006616A1 Quinazolinone pharmaceuticals and use thereof
03/07/1996WO1996006615A1 Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides
03/07/1996WO1996006614A1 Novel antibiotic compounds and methods to treat gram-positive bacterial and mycoplasmal infections
03/07/1996WO1996006613A1 Topical ketoconazole emulsions
03/07/1996WO1996006612A1 Method and composition for treating cystic fibrosis
03/07/1996WO1996006611A1 Anti-inflammatory compounds
03/07/1996WO1996006610A1 Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system
03/07/1996WO1996006609A1 Inhibitors of farnesyl-protein transferase
03/07/1996WO1996006608A1 Process for reducing the adverse taste and malodor associated with h2-antagonists
03/07/1996WO1996006607A1 Indole alkaloids useful as uv protective and anti-inflammatory agents
03/07/1996WO1996006606A1 Dihydro-2,3-benzodiazepine derivatives
03/07/1996WO1996006605A1 Method of reducing body fat in animals by the administration of conjugated linoleic acid
03/07/1996WO1996006604A2 Methods for identifying and treating resistant tumors
03/07/1996WO1996006601A1 Use of 5-ht ligands as anti-pruritic agents
03/07/1996WO1996006600A1 Transdermal therapeutic system with protection against hydrolysis
03/07/1996WO1996006599A1 Taste-making lipid-based liquid medicinal composition
03/07/1996WO1996006530A1 Method of treating inflammatory liver, pancreatic and intestinal disorders
03/07/1996WO1996006528A1 Ionene polymers containing biologically-active anions
03/07/1996WO1996006527A1 Sprayable film forming system releasing active substances for use on plants
03/07/1996WO1996003515A3 Surface expression of enzyme in gene directed prodrug therapy
03/07/1996WO1995019777A3 Use of diesters of muramyl peptides in oral form as immunostimulating agents
03/07/1996DE4431251A1 Skin cream, and base cream for cosmetics, eczema etc.
03/07/1996DE4431122A1 Neue Thiazolo[3,2-a]chinolin- und -naphthyridinderivate New thiazolo [3,2-a] quinoline and -naphthyridinderivate
03/07/1996DE4430910A1 Medicament for treating tinnitus
03/07/1996DE4430757A1 Neue 4-Aminopyridazine, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel New 4-Aminopyridazine, process for their preparation and pharmaceutical compositions containing them
03/07/1996DE4430755A1 Neue Phosphanoxide, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel New phosphine oxides, processes for their preparation and pharmaceutical compositions containing them
03/07/1996DE4430639A1 Verwendung von 5-substituierten Pyridin- und Hexahydrochinolin-3-carbonsäurederivaten Use of 5-substituted pyridine and hexahydroquinoline-3-carboxylic acid derivatives
03/07/1996CA2198908A1 Method for controlling o-desulfation of heparin and compositions produced thereby
03/07/1996CA2198752A1 Methods for identifying and treating resistant tumors
03/07/1996CA2198739A1 Novel antibiotic compounds and methods to treat gram-positive bacterial and mycoplasmal infections
03/07/1996CA2198728A1 Neurotrophic and antiproliferative compounds
03/07/1996CA2198726A1 Inhibitors of farnesyl-protein transferase
03/07/1996CA2198722A1 Antithrombotic and non-hemorrhagic heparin-based compositions, process for their preparation and therapeutic applications
03/07/1996CA2198721A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound
03/07/1996CA2198616A1 New thiazolo[3,2-a]quinoline and thiazolo[3,2-a]naphthyridine derivatives
03/07/1996CA2198495A1 Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system
03/07/1996CA2198462A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
03/07/1996CA2198457A1 Isoxazole derivatives
03/07/1996CA2198366A1 Novel 4-aminopyridazines, processes for their production as well as pharmaceutical agents
03/07/1996CA2198365A1 Novel phosphane oxides, method of preparing them and drugs containing these compounds
03/07/1996CA2198097A1 Spirostanyl glycosidal crystals
03/07/1996CA2197895A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
03/07/1996CA2197566A1 New peptide derivatives with .delta. opioid receptor antagonist or mixed.mu. agonist/.delta. antagonist effects
03/07/1996CA2196063A1 Cosolvent parenteral formulation of tirilazad
03/07/1996CA2194876A1 Bioadhesive-wound healing composition
03/06/1996EP0699689A1 Branched polysaccharide, microorganism producing it and compositions containing them
03/06/1996EP0699682A1 Process for the preparation and/or purification of clavulanic acid
03/06/1996EP0699681A1 Cephalosporin derivatives
1 ... 6936 6937 6938 6939 6940 6941 6942 6943 6944 6945 6946 6947 6948 6949 6950 6951 6952 6953 6954 6955 6956 ... 7860